CAVE CREEK, AZ - (NewMediaWire) - November 4, 2015 - Endexx Corporation (OTC PINK: EDXC), a provider of innovative medical marijuana management and technology solutions, updates shareholders on new developments and the growth of its Cannsumables© division.
Endexx has tested multiple CBD products from many suppliers over the past 12 months. Endexx has consolidated strategic relationships with a few key suppliers of high-grade CBD extracts, oils and isolates. The raw supply is imported from industrial hemp farmed in Europe and from a premium Colorado hemp grower and processor operating under a license from the Colorado Department of Agriculture.
Endexx has developed new product lines and will be launching products for optimized oral delivery and for vaping aficionados. Formulations are naturally flavored with terpenes and essential oils, and are diabetic friendly. Endexx is finalizing novel delivery systems from isolate and oil extracts with formulations that can be used in a frozen form or as an energy shot. One of the most exciting and ground breaking developments to go to market before the end of the year is a water soluble solution that is currently being tested for stability and for its superior bioavailability properties. A preliminary test can be viewed HERE.
Distribution is growing with two divisions, CBDunlimited.com and CBD Health Solutions, retail distribution in health food stores, sports nutrition outlets, vape shops, dispensaries and an expanding network of wholesale distributors. Endexx is also building a long-term growth strategy with marketing and distribution partners specializing in brand awareness, visibility, social media and with a focus on driving sales.
On November 1st, Todd Davis, Endexx CEO, was a guest on "Healthy House Call" a daily radio show with Dr. Koontz on KFNX 1100 AM in Phoenix, AZ. The subject was "Phytonutrients for Health". Click HERE to listen. Additionally, the products are now being featured at Healthy Habit Health Foods store in Phoenix, AZ.
Todd Davis, Endexx CEO, stated: "We have presented our Cannsumable products on three national radio shows in the last few months. Response has been excellent and we have acquired many new customers. Testimonies keep coming in from our customers, notifying us of the benefits they have experienced from the products we provide. The learning curve is steep for the market as a whole, but based on feedback from our customers, the value of CBD-based products is going to explode into the market place. Endexx is positioning to be a leader in this market through quality products backed by research and science. We highly encourage our shareholders to try our products and understand their true value."
Endexx provides innovative medical marijuana management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phyto-cannabinoids. The company has two technology products and services that launched in 2014 -- the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to an eventual federal mandate. The Autospense™ is a high-tech marijuana inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailer, while enhancing their service quality by reducing transaction time for customers. Websites include: www.cbdunlimited.com, www.endexx.com, www.m3hub.com.
Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.